The ESPACOMP and its role in promoting knowledge and competencies in the matter of patient adherence

Schneider, M.; Bouvy, Marcel L.

doi:10.1007/s11096-013-9879-4

Cited by 1 publication

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since the initial think tank meeting (2011), there is heightened awareness of medication adherence as a problem on both the national 2 – 4 and international stage. 2 , 10 , 11 There is also increasing attention on raising awareness about the problem of poor adherence by educating and engaging patients, their families, and caregivers. 5 Despite much attention and the development of numerous interventions aimed at improving medication adherence, 6 – 8 adherence generally remains low and is a continuing public health concern.…”

Section: How Has Medication Adherence Evolved?mentioning

confidence: 99%

“…One example of an international partner is the European Society for Patient Adherence, COMpliance and Persistence (ESPACOMP). 11 ESPACOMP is a predominately European “nonprofit association established to promote the science concerned with the quantitative assessment of what patients do with medicines they have been prescribed”. 11 The group orga-nizes annual symposiums reaching clinical, research, and industry partners focused on medication adherence from multiple countries and continents.…”

Section: Can We Develop Specific Recommendations To Transform Clinicamentioning

confidence: 99%

See 1 more Smart Citation

A renewed Medication Adherence Alliance call to action: harnessing momentum to address medication nonadherence in the United States

Zullig¹,

Granger²,

Bosworth³

2016

PPA

View full text Add to dashboard Cite

The problemNonadherence to prescription medications is a common and costly problem with multiple contributing factors, spanning the dimensions of individual behavior change, psychology, medicine, and health policy, among others. Addressing the problem of medication nonadherence requires strategic input from key experts in a number of fields.Meeting of expertsThe Medication Adherence Alliance is a group of key experts, predominately from the US, in the field of medication nonadherence. Members include representatives from consumer advocacy groups, community health providers, nonprofit groups, the academic community, decision-making government officials, and industry. In 2015, the Medication Adherence Alliance convened to review the current landscape of medication adherence. The group then established three working groups that will develop recommendations for shifting toward solutions-oriented science.Commentary of expert opinionFrom the perspective of the Medication Adherence Alliance, the objective of this commentary is to describe changes in the US landscape of medication adherence, framing the evolving field in the context of a recent think tank meeting of experts in the field of medication adherence.

show abstract

Section: How Has Medication Adherence Evolved?mentioning

confidence: 99%

Section: Can We Develop Specific Recommendations To Transform Clinicamentioning

confidence: 99%

A renewed Medication Adherence Alliance call to action: harnessing momentum to address medication nonadherence in the United States

Zullig¹,

Granger²,

Bosworth³

2016

PPA

View full text Add to dashboard Cite

show abstract

The ESPACOMP and its role in promoting knowledge and competencies in the matter of patient adherence

Cited by 1 publication

References 5 publications

A renewed Medication Adherence Alliance call to action: harnessing momentum to address medication nonadherence in the United States

A renewed Medication Adherence Alliance call to action: harnessing momentum to address medication nonadherence in the United States

Contact Info

Product

Resources

About